Recent health developments include Eli Lilly's Alzheimer's treatment approval in China, a DOJ lawsuit against CVS for opioid ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Kathy Ingebrand of Mahtomedi is one of the first people in the country to receive the infusion meant to slow down Alzheimer's disease by up to 35%.

It’s important to connect with loved ones this time of year but when Alzheimer’s is in the mix, it can be extra stressful.

EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8)(Reuters ...

(Corrects paragraph 8 of Dec. 17 story to reflect that the EU regulator reversed its July decision in November to recommend ...

The summary highlights significant activities in the health sector, including Eli Lilly's Alzheimer's treatment approval in ...

What is considered “high” blood pressure? How can you lower it? Dr. Muhammad Siyab Panhwar, a board-certified interventional cardiologist at Sanford Health of Minnesota, answers some of the most ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Eli Lilly (LLY) stock in focus as China approves its Alzheimer's treatment Kisunla (donanemab). Read more here.

What Eli Lilly (NYSE: LLY) is doing is far more impressive. While many investors may buy it for its growth potential, here's ...